PetMed Express Inc. (PETS) Insider Bruce S. Rosenbloom Sells 1,500 Shares
PetMed Express Inc. (NASDAQ:PETS) insider Bruce S. Rosenbloom sold 1,500 shares of the business’s stock in a transaction on Monday, October 10th. The shares were sold at an average price of $21.00, for a total transaction of $31,500.00. Following the transaction, the insider now owns 41,767 shares in the company, valued at approximately $877,107. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
PetMed Express Inc. (NASDAQ:PETS) opened at 20.38 on Thursday. The firm’s 50-day moving average is $20.41 and its 200 day moving average is $19.29. PetMed Express Inc. has a 12-month low of $15.61 and a 12-month high of $21.16. The firm has a market cap of $411.27 million, a P/E ratio of 19.41 and a beta of 1.07.
PetMed Express (NASDAQ:PETS) last issued its quarterly earnings results on Monday, July 25th. The company reported $0.32 EPS for the quarter, beating analysts’ consensus estimates of $0.31 by $0.01. PetMed Express had a net margin of 9.09% and a return on equity of 25.97%. The business had revenue of $72.50 million for the quarter. During the same quarter in the previous year, the business earned $0.29 earnings per share. The firm’s revenue was up 1.3% on a year-over-year basis. Equities analysts forecast that PetMed Express Inc. will post $1.11 earnings per share for the current year.
Hedge funds and other institutional investors have recently modified their holdings of the company. NEXT Financial Group Inc boosted its position in shares of PetMed Express by 167.2% in the second quarter. NEXT Financial Group Inc now owns 5,354 shares of the company’s stock valued at $100,000 after buying an additional 3,350 shares in the last quarter. BNP Paribas Arbitrage SA boosted its position in shares of PetMed Express by 101.2% in the second quarter. BNP Paribas Arbitrage SA now owns 6,206 shares of the company’s stock valued at $116,000 after buying an additional 3,121 shares in the last quarter. Royal Bank of Canada boosted its position in shares of PetMed Express by 19.6% in the second quarter. Royal Bank of Canada now owns 6,423 shares of the company’s stock valued at $120,000 after buying an additional 1,053 shares in the last quarter. Cutler Group LP boosted its position in shares of PetMed Express by 832.0% in the second quarter. Cutler Group LP now owns 7,064 shares of the company’s stock valued at $132,000 after buying an additional 8,029 shares in the last quarter. Finally, Bank of Montreal Can purchased a new position in shares of PetMed Express during the second quarter valued at about $143,000. Hedge funds and other institutional investors own 75.97% of the company’s stock.
A number of research analysts recently issued reports on PETS shares. Zacks Investment Research upgraded shares of PetMed Express from a “hold” rating to a “buy” rating and set a $23.00 target price on the stock in a research report on Wednesday, July 27th. Credit Suisse Group AG reiterated a “sell” rating and set a $13.00 target price on shares of PetMed Express in a research report on Tuesday, August 16th.
PetMed Express Company Profile
PetMed Express, Inc (PetMed Express), doing business as 1800PetMeds, is a pet pharmacy. The Company markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. It offers a selection of products for dogs and cats. Its product line contains approximately 3,000 stock keeping units (SKUS) of pet medications, health products and supplies.
Receive News & Stock Ratings for PetMed Express Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express Inc. and related stocks with our FREE daily email newsletter.